← FDA DRUG APPROVALS

FDA ANDA · ANDA091465

DEXMEDETOMIDINE HYDROCHLORIDE

Sponsor: CAPLIN

APPLICATION
ANDA091465
TYPE
ANDA
ORIGINAL APPROVAL
2016-06-14
LATEST ACTION
2020-06-22
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

DEXMEDETOMIDINE HYDROCHLORIDEDiscontinued
DEXMEDETOMIDINE HYDROCHLORIDE EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) · INJECTABLE · INJECTION

Approval history

2020-06-22Labeling · Supplement 2 · standardAP
2016-06-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →